Spark Investment Management’s Fresh Tracks Therapeutics, Inc. Common Stock FRTX Stock Holding History

Spark Investment Management’s Portfolio FRTX Stock Details FRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-21	Closed	-$25K	–	864
2016 Q1	$25K	Sell	21 -48	-70%	-$55.4K	﹤0.01%	752
2015 Q4	$89K	Hold	69	–	–	0.01%	672
2015 Q3	$98K	Sell	69 -2	-3%	-$3.86K	0.01%	605
2015 Q2	$152K	Buy	71 +2	+3%	+$6.27K	0.02%	567
2015 Q1	$204K	Hold	69	–	–	0.03%	548
2014 Q4	$224K	Buy	69 +20	+41%	+$70.8K	0.04%	469
2014 Q3	$172K	Buy	49 +21	+75%	+$81.6K	0.03%	533
2014 Q2	$105K	Buy	+28	New	+$105K	0.02%	559

Other funds holding FRTX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

CAM

ClariVest Asset Management San Diego, California $980M AUM 60.89% 1-Year Est. Return

EGA

Eagle Global Advisors Houston, Texas $3.02B AUM 34.37% 1-Year Est. Return

Spark Investment Management's FRTX Position: Q2 2016 in Review

Spark Investment Management sold out of Fresh Tracks Therapeutics, Inc. Common Stock (FRTX) in Q2 2016, closing a stake of 21 shares — an estimated $25K sold.

Spark Investment Management first reported a position in FRTX in Q2 2014 and held it in 8 quarters. The position peaked at $224K in Q4 2014. 36 funds tracked by Wall St. Rank hold FRTX as of Q2 2016.

Spark Investment Management reported no remaining Fresh Tracks Therapeutics, Inc. Common Stock position as of Q2 2016 after selling out during the quarter.
Spark Investment Management sold 21 Fresh Tracks Therapeutics, Inc. Common Stock shares in Q2 2016, an estimated $25K.
Spark Investment Management first reported a position in Fresh Tracks Therapeutics, Inc. Common Stock in Q2 2014 and held it in 8 quarters.
Spark Investment Management's Fresh Tracks Therapeutics, Inc. Common Stock position peaked at $224K in Q4 2014.
36 funds tracked by Wall St. Rank held Fresh Tracks Therapeutics, Inc. Common Stock as of Q2 2016.

Based on Spark Investment Management's 13F filing for Q2 2016, filed 12 Aug 2016.